Showing 341 - 360 results of 1,266 for search '"Lung cancer"', query time: 0.10s Refine Results
  1. 341
  2. 342
  3. 343

    Hydrodissection technique for pain relief during peri-microwave ablation in patients with subpleural non-small cell lung cancers by Nan Wang, Tianyu Xue, Peng Liu, Pikun Cao, Jingwen Xu, Zhigang Wei, Xin Ye

    Published 2024-12-01
    “…Purpose This study aimed to assess the application value of the hydrodissection technique (HT) for pain relief during peri-microwave ablation (MWA) in patients with subpleural non-small cell lung cancers (NSCLCs).Methods This retrospective study comprised 218 patients with subpleural NSCLCs who underwent computed tomography (CT)-guided percutaneous MWA. …”
    Get full text
    Article
  4. 344
  5. 345
  6. 346
  7. 347
  8. 348
  9. 349

    A Case of Long-Term Survival after Checkpoint Inhibitor Pneumonitis in a Patient with Squamous Cell Lung Cancer by Hironori Ashinuma, Satoko Mizuno, Yasushi Yoshida, Masato Shingyoji

    Published 2019-01-01
    “…We herein report the case of a woman with squamous cell lung cancer who was a long-term survivor after CIP. …”
    Get full text
    Article
  10. 350
  11. 351
  12. 352
  13. 353
  14. 354

    Lesser Toxicities of Belotecan in Patients with Small Cell Lung Cancer: A Retrospective Single-Center Study of Camptothecin Analogs by Yeon Hee Park, Chae Uk Chung, Bo Mi Park, Myoung Rin Park, Dong Il Park, Jae Young Moon, Hee Sun Park, Jin Hwan Kim, Sung Soo Jung, Ju Ock Kim, Sun Young Kim, Jeong Eun Lee

    Published 2016-01-01
    “…Topotecan and belotecan are camptothecin derivatives that are used to treat small cell lung cancer (SCLC). This study compared the toxicities and efficacies of belotecan and topotecan monotherapies in patients with SCLC. …”
    Get full text
    Article
  15. 355

    A benchmark of deep learning approaches to predict lung cancer risk using national lung screening trial cohort by Yifan Jiang, Leyla Ebrahimpour, Philippe Després, Venkata SK. Manem

    Published 2025-01-01
    “…Abstract Deep learning (DL) methods have demonstrated remarkable effectiveness in assisting with lung cancer risk prediction tasks using computed tomography (CT) scans. …”
    Get full text
    Article
  16. 356
  17. 357
  18. 358
  19. 359

    Putting COPD and Lung Cancer Guidelines Into Practice: A Canadian Thoracic Society and American College of Chest Physicians Perspective

    Published 2004-01-01
    “…Update your knowledge on lung cancer as presented by contributors to the 2003 ACCP Evidence-Based Guidelines on Lung Cancer. …”
    Get full text
    Article
  20. 360

    Utilizing TP53 hotspot mutations as effective predictors of gemcitabine treatment outcome in non-small-cell lung cancer by Yen-Han Tseng, Trieu Thi My Tran, Jinghua Tsai Chang, Yu-Tang Huang, Anh Thuc Nguyen, Ian Yi‑Feng Chang, Yi-Tung Chen, Hao-Wen Hsieh, Yue-Li Juang, Peter Mu-Hsin Chang, Tzu-Yi Huang, Ying-Chih Chang, Yuh-Min Chen, Hsuan Liu, Chi-Ying F. Huang

    Published 2025-01-01
    “…Abstract TP53 mutations are recognized to correlate with a worse prognosis in individuals with non-small cell lung cancer (NSCLC). There exists an immediate necessity to pinpoint selective treatment for patients carrying TP53 mutations. …”
    Get full text
    Article